Healthcare News and Research

Latest Healthcare News and Research

Limited options for managing UTIs make women fearful and frustrated

Despite the prevalence of the painful condition, women are fearful and frustrated with limited management options, according to Cedars-Sinai research published in the Journal of Urology.

2 Oct 2021

Scientists identify potential treatment for previously unknown condition affecting children

Researchers from the Agency for Science, Technology and Research's (A*STAR) Genome Institute of Singapore (GIS), and Rady Children's Institute for Genomic Medicine identified a previously unknown condition affecting children, which they discovered could be prevented by administering a drug during pregnancy.

2 Oct 2021

Providing better mental health treatment for adolescents with disabilities

Many teens with intellectual and developmental disabilities receive care coordination services from a Maternal and Child Health Bureau-funded state agency.

2 Oct 2021

WHO and partners launch the first ever global strategy to defeat meningitis

Today, the World Health Organization and partners launched the first ever global strategy to defeat meningitis - a debilitating disease that kills hundreds of thousands of people each year.

1 Oct 2021

UVA researchers identify 14 genes that cause obesity

Promising news in the effort to develop drugs to treat obesity: University of Virginia scientists have identified 14 genes that can cause and three that can prevent weight gain. The findings pave the way for treatments to combat a health problem that affects more than 40% of American adults.

1 Oct 2021

EKF Diagnostics appoints Luke Daum as Chief Scientific Officer

EKF Diagnostics, the global in vitro diagnostics company, has appointed Luke Daum PhD as Chief Scientific Officer, bringing a wealth of expertise in molecular-based diagnostics to EKF’s leadership team.

From EKF Diagnostics 1 Oct 2021

3D training models to improve knee, hip and spine surgeries

Knee, hip and spinal surgery is the focus of a major new research project focusing on 3D technology developed in South Australia.

1 Oct 2021

Yokogawa Invests in CyberneX, Developer of a Technology for Measuring Brainwaves with a High-performance Earphone-type Device

Yokogawa announces that it has invested in CyberneX Co., Ltd., a startup that has developed an earphone-type device capable of measuring brainwaves in real-time.

From Yokogawa Life Science 1 Oct 2021

Study reveals how the blood and immune systems develop in prenatal bone marrow

The first comprehensive analysis of how the blood and immune systems develop in prenatal bone marrow has been conducted by scientists at the Wellcome Sanger Institute, Newcastle University and their collaborators.

1 Oct 2021

New report evaluates the impact of climate change on health

Tomorrow, Wednesday 29th September, the Action for Global Health network will release a new report on “Health Inequalities and Climate Change”, calling for ambitious action to tackle climate change for the health of people and the planet.

1 Oct 2021

A call to action for reducing health disparities and advancing treatments for Parkinson's patients

Current knowledge about Parkinson's disease (PD) does not reflect the diversity of people with the disease, according to The Michael J. Fox Foundation for Parkinson's Research (MJFF).

1 Oct 2021

Scientists find new possibilities for treatment of lung cancers in 'never smokers'

Despite smoking's well-known role in causing lung cancer, a significant number of patients who develop lung tumors have never smoked. While scientists are still working to understand what spurs cancer in so-called "never-smokers," a study led by scientists at Washington University School of Medicine in St. Louis demonstrates new possibilities for treating these baffling tumors.

1 Oct 2021

Comparison of Pfizer, Moderna, J&J, AZ vaccines for neutralization titer, against Delta and other variants

Is one COVID vaccine better than the other? Four current vaccines — Moderna, Pfizer-BioNTech, Johnson & Johnson, and AstraZeneca — are highly effective against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), but a new medRxiv* study suggests the level of protection varies.

30 Sep 2021

Pediatric transplant recipients mount a more robust immune response after two COVID-19 vaccine doses

In a study published today in the American Journal of Transplantation, Johns Hopkins Medicine researchers say that children between the ages of 12 and 18 who have received solid organ transplants appear to mount a more robust immune response than their adult counterparts after a standard two-dose vaccination regimen against SARS-CoV-2, the virus that causes COVID-19.

30 Sep 2021